{
  "guid": "http://files.libertyfund.org/econtalk/y2010/Epsteinregulation.mp3",
  "title": "Richard Epstein on Regulation",
  "description": "<p>Richard Epstein of New York University and Stanford University's Hoover Institution talks with EconTalk host Russ Roberts about the current state of the economy, particularly the regulatory climate. Epstein argues the current level of regulation is producing unusually high costs. He digs more deeply into the pharmaceutical industry and discusses various regulations and alternative ways to encourage drug safety and innovation.</p>\n",
  "pubDate": "Mon, 20 Sep 2010 06:30:00 +0000",
  "author": "webmaster@econlib.org (Library of Economics and Liberty)",
  "link": "https://www.econtalk.org/richard-epstein-on-regulation/",
  "content:encoded": "<p>Richard Epstein of New York University and Stanford University's Hoover Institution talks with EconTalk host Russ Roberts about the current state of the economy, particularly the regulatory climate. Epstein argues the current level of regulation is producing unusually high costs. He digs more deeply into the pharmaceutical industry and discusses various regulations and alternative ways to encourage drug safety and innovation.</p>\n",
  "enclosure": "",
  "itunes:title": "Richard Epstein on Regulation",
  "itunes:author": "Library of Economics and Liberty",
  "itunes:duration": "01:07:06",
  "itunes:summary": "Richard Epstein of New York University and Stanford University's Hoover Institution talks with EconTalk host Russ Roberts about the current state of the economy, particularly the regulatory climate. Epstein argues the current level of regulation is producing unusually high costs. He digs more deeply into the pharmaceutical industry and discusses various regulations and alternative ways to encourage drug safety and innovation.",
  "itunes:subtitle": "Richard Epstein of New York University and Stanford University's Hoover Institution talks with EconTalk host Russ Roberts about the current state of the economy, particularly the regulatory climate. Epstein argues the current level of regulation is producing unusually high costs. He digs more deeply into the pharmaceutical industry and discusses various regulations and alternative ways to encourage drug safety and innovation.",
  "itunes:keywords": "economics, econlib, drug safety, fda, richard epstein, pharmaceuticals",
  "itunes:explicit": "no",
  "itunes:episodeType": "full",
  "itunes:episode": 229
}